Edition:
United States

Profile: Baxter International Inc (BAX.N)

BAX.N on New York Stock Exchange

49.73USD
17 Feb 2017
Change (% chg)

$0.31 (+0.63%)
Prev Close
$49.42
Open
$49.32
Day's High
$49.74
Day's Low
$49.32
Volume
786,744
Avg. Vol
952,766
52-wk High
$50.16
52-wk Low
$37.37

Baxter International Inc., incorporated on October 19, 1931, through its subsidiaries, provides a portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics, and pharmacy automation, software and services. The Company operates through two segments: Hospital Products and Renal. The Company's products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices and by patients at home under physician supervision. The Company manufactures products in approximately 30 countries and sells them in approximately 120 countries.

The Company's Hospital Products business manufactures IV solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, inhalation anesthetics, and biosurgery products. The business also provides products and services related to pharmacy compounding, and drug formulation. The Renal business provides products and services to treat end-stage renal disease, or irreversible kidney failure and acute kidney injuries. The Renal business offers a portfolio to meet the needs of patients across the treatment continuum, including technologies and therapies for peritoneal dialysis (PD), in-center hemodialysis (HD), home HD (HHD), continuous renal replacement therapy (CRRT) and additional dialysis services.

Company Address

Baxter International Inc

One Baxter Pkwy, Df2-1W
DEERFIELD   IL   60015-4625
P: +1847.9482000
F: +1302.6555049

Company Web Links